ARWR: Arrowhead Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,417.34
Enterprise Value ($M) 2,125.23
Book Value ($M) 56.08
Book Value / Share 0.44
Price / Book 25.52
NCAV ($M) -387.08
NCAV / Share -3.07
Price / NCAV -3.66

Profitability (mra)
Return on Invested Capital (ROIC) -0.69
Return on Assets (ROA) -0.67
Return on Equity (ROE) -1.29

Liquidity (mrq)
Quick Ratio 6.09
Current Ratio 6.09

Balance Sheet (mrq) ($M)
Current Assets 570.54
Assets 1,013.69
Liabilities 957.62
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3.55
Operating Income -601.08
Net Income -599.49
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -462.85
Cash from Investing -420.07
Cash from Financing 870.52

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13D Sarepta Therapeutics, Inc. 9.50
02-14 13G/A Avoro Capital Advisors LLC 9.60 35.32
02-05 13G State Street Corp 4.80 -5.32
2024-04-10 13G/A Vanguard Group Inc 10.01 16.23

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 315,080 2,105,290 14.97
2025-04-16 600,938 3,475,480 17.29
2025-04-15 364,249 1,658,736 21.96
2025-04-14 282,191 1,186,891 23.78

(click for more detail)

Similar Companies
APLS – Apellis Pharmaceuticals, Inc. ARQT – Arcutis Biotherapeutics, Inc.
ARVN – Arvinas, Inc. ASMB – Assembly Biosciences, Inc.
ATRA – Atara Biotherapeutics, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Arrowhead Pharmaceuticals